Human LAPTM4A has 46% amino acid homology with human LAPTM4B, another LAPTM family member involved in tumor progression (Meng et al., 2016) and lysosomal ceramide transport (Blom et al., 2015) (Figure 4A). The gene discussed is LAPTM4A; the disease is neoplasm.